SenoVac AI Discovery Platform
神诺威AI药物发现平台
AI Platform
AI平台
Decoding senescence. Directing precision clearance.
解码衰老，导向精准清除。
Built on SenoVac's expertise in aging biology and immune clearance, our AI platform turns scientific insight into therapeutic opportunity, uncovering tissue-selective seno-antigens and expanding treatment possibilities for age-related diseases.
依托神诺威在衰老生物学与免疫清除领域的长期积累，AI平台将科研洞见转化为可推进的药物机会，持续发现具有组织选择性的Seno-antigen，拓展衰老相关疾病的治疗边界。
Explore the Platform探索平台
A biology-first discovery engine
以生物学为起点的发现引擎
From Seno-antigen to Therapeutic Opportunity
从Seno-antigen走向治疗机会
The platform identifies what distinguishes pathological senescent cells, directs each target toward a suitable immune-clearance strategy, and keeps every decision connected to experimental validation.
平台识别病理性衰老细胞与健康组织之间的关键差异，为每个靶点匹配更合适的免疫清除路径，并让每一次研发判断始终连接实验验证。
Designed around senescence biology
围绕衰老生物学构建
AI-Guided Candidate Design
AI辅助候选设计
The AI platform turns SenoVac's seno-antigen landscape into candidate-design decisions. It helps connect target biology with therapeutic-path selection, candidate optimization and the evidence required for the next experiment.
AI平台将神诺威的Seno-antigen靶点版图转化为候选设计决策，连接靶点生物学、治疗路径选择、候选优化与下一步实验所需的验证依据。
Distinguish pathological senescent cells from healthy tissue.
识别病理性衰老细胞与健康组织之间可转化的关键差异。
Focus development where precision and a therapeutic window can converge.
聚焦更有希望兼顾精准识别与治疗窗口的靶点机会。
Keep AI-assisted optimization aligned with immune-clearance biology and experimental proof.
让AI辅助优化始终与免疫清除机制和实验验证保持一致。